Rapidly progressive glomerulonephritis historical perspective: Difference between revisions
Created page with "__NOTOC__ {{Rapidly progressive glomerulonephritis}} {{CMG}}; {{AE}} {{AEL}} ==Overview== ==Historical perspective== ==References== {{reflist|2}}" |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AEL}} | {{CMG}}; {{AE}} {{AEL}} | ||
==Overview== | ==Overview== | ||
==Historical perspective== | RPGN was discovered in 1958 by Australians Stanton and Tait. | ||
==Historical perspective== | |||
* Ernst Goodpasture made case reports about glomerulnophritis and pulmonary haemorrhages in 1919. | |||
* Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome. in 1958. | |||
* They gave the anti GBM antibodies classification and discovered RPGN in these cases. | |||
* In 1960s, electron microscopy and immunofluorescence helped learn RPNG on immunological level. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:01, 24 July 2018
|
Rapidly progressive glomerulonephritis Microchapters |
|
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Rapidly progressive glomerulonephritis historical perspective On the Web |
|
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis historical perspective |
|
FDA on Rapidly progressive glomerulonephritis historical perspective |
|
CDC on Rapidly progressive glomerulonephritis historical perspective |
|
Rapidly progressive glomerulonephritis historical perspective in the news |
|
Blogs on Rapidly progressive glomerulonephritis historical perspective |
|
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
|
Risk calculators and risk factors for Rapidly progressive glomerulonephritis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
RPGN was discovered in 1958 by Australians Stanton and Tait.
Historical perspective
- Ernst Goodpasture made case reports about glomerulnophritis and pulmonary haemorrhages in 1919.
- Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome. in 1958.
- They gave the anti GBM antibodies classification and discovered RPGN in these cases.
- In 1960s, electron microscopy and immunofluorescence helped learn RPNG on immunological level.